Prior Auth Tied to Delays, Discontinuation of Cancer Meds
The introduction of a new prior authorization requirement for an established oral anticancer regimen led to more treatment delays and discontinuations among Medicare beneficiaries.
Medscape Medical News
source https://www.medscape.com/viewarticle/new-prior-auth-policy-tied-delays-discontinuation-oral-2024a100009g?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/new-prior-auth-policy-tied-delays-discontinuation-oral-2024a100009g?src=rss
Comments
Post a Comment